The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ACTAIR 100 IR sublingual tablets


Main Information

Trade NameACTAIR 100 IR sublingual tablets
Active SubstancesDermatophagoides Pteronyssinus Extract
Dermatophagoides Farinae Extract
Dosage FormSublingual tablet
Licence NumberPA2113/002/001

Group Information

ATC CodeV01AA03 house dust mites


License statusAuthorised
Licence Issued08/10/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back